ZNF335
Basic information
Region (hg38): 20:45948660-45972203
Links
Phenotypes
GenCC
Source:
- microcephalic primordial dwarfism due to ZNF335 deficiency (Strong), mode of inheritance: AR
- microcephalic primordial dwarfism due to ZNF335 deficiency (Supportive), mode of inheritance: AR
- microcephalic primordial dwarfism due to ZNF335 deficiency (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microcephaly 10, primary, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 23178126 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- Microcephalic primordial dwarfism due to ZNF335 deficiency (2 variants)
- Inborn genetic diseases (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF335 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 104 | 116 | ||||
missense | 234 | 18 | 258 | |||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 8 | 25 | 6 | 39 | ||
non coding | 52 | 36 | 93 | |||
Total | 8 | 6 | 251 | 175 | 49 |
Highest pathogenic variant AF is 0.0000329
Variants in ZNF335
This is a list of pathogenic ClinVar variants found in the ZNF335 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-45948675-C-G | Likely benign (Dec 05, 2018) | |||
20-45948675-C-T | Benign (Jul 27, 2018) | |||
20-45948956-G-A | Likely benign (Nov 27, 2023) | |||
20-45948962-G-A | ZNF335-related disorder | Likely benign (Feb 02, 2022) | ||
20-45948976-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
20-45948979-C-T | Inborn genetic diseases | Uncertain significance (Feb 01, 2023) | ||
20-45948981-T-C | Uncertain significance (Sep 27, 2022) | |||
20-45948984-T-C | Microcephalic primordial dwarfism due to ZNF335 deficiency | Uncertain significance (Mar 02, 2022) | ||
20-45948998-C-G | Uncertain significance (Mar 20, 2023) | |||
20-45949009-G-C | Inborn genetic diseases | Uncertain significance (Sep 20, 2022) | ||
20-45949018-C-G | Uncertain significance (Jun 02, 2022) | |||
20-45949018-C-T | Uncertain significance (Jan 15, 2022) | |||
20-45949019-G-A | ZNF335-related disorder | Benign (Oct 22, 2023) | ||
20-45949030-C-T | Uncertain significance (Jun 28, 2022) | |||
20-45949031-G-A | Likely benign (Mar 18, 2022) | |||
20-45949069-C-T | Inborn genetic diseases | Uncertain significance (Aug 21, 2023) | ||
20-45949070-A-T | Uncertain significance (Jun 20, 2022) | |||
20-45949085-C-T | Uncertain significance (Dec 07, 2023) | |||
20-45949163-T-G | Likely benign (Jun 13, 2022) | |||
20-45949182-AGT-A | Microcephalic primordial dwarfism due to ZNF335 deficiency | Uncertain significance (Jan 13, 2021) | ||
20-45949183-G-T | Uncertain significance (Dec 02, 2021) | |||
20-45949186-T-C | Likely benign (Nov 27, 2023) | |||
20-45949193-G-A | Uncertain significance (Aug 23, 2022) | |||
20-45949203-G-A | Microcephalic primordial dwarfism due to ZNF335 deficiency | Likely benign (Aug 31, 2022) | ||
20-45949213-G-A | not specified | Likely benign (Dec 29, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF335 | protein_coding | protein_coding | ENST00000322927 | 27 | 23542 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.89e-7 | 1.00 | 125637 | 2 | 109 | 125748 | 0.000441 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.550 | 795 | 840 | 0.947 | 0.0000529 | 8673 |
Missense in Polyphen | 280 | 326.9 | 0.85652 | 3389 | ||
Synonymous | -0.632 | 360 | 345 | 1.04 | 0.0000228 | 2771 |
Loss of Function | 4.83 | 23 | 65.0 | 0.354 | 0.00000335 | 710 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000687 | 0.000685 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000544 | 0.000544 |
Finnish | 0.000435 | 0.000416 |
European (Non-Finnish) | 0.000546 | 0.000501 |
Middle Eastern | 0.000544 | 0.000544 |
South Asian | 0.000300 | 0.000294 |
Other | 0.00115 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters. Enhances ligand- dependent transcriptional activation by nuclear hormone receptors. Plays an important role in neural progenitor cell proliferation and self-renewal through the regulation of specific genes involved brain development, including REST. Also controls the expression of genes involved in somatic development and regulates, for instance, lymphoblast proliferation. {ECO:0000269|PubMed:12215545, ECO:0000269|PubMed:18180299, ECO:0000269|PubMed:23178126}.;
- Disease
- DISEASE: Microcephaly 10, primary, autosomal recessive (MCPH10) [MIM:615095]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age- related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH10 is characterized by extremely small head size and death usually by 1 year of age. Neuropathologic examination shows severe loss of neurons as well as neuronal loss of polarity and abnormal dendritic maturation. {ECO:0000269|PubMed:23178126}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.625
- rvis_EVS
- -1.12
- rvis_percentile_EVS
- 6.62
Haploinsufficiency Scores
- pHI
- 0.321
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.972
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfp335
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- in utero embryonic development;positive regulation of neuroblast proliferation;regulation of transcription by RNA polymerase II;brain development;regulation of gene expression;cerebral cortex neuron differentiation;regulation of gene expression, epigenetic;neuron projection morphogenesis;brain morphogenesis;positive regulation of lymphocyte proliferation;positive regulation of neurogenesis;regulation of histone H3-K4 methylation;histone H3-K4 trimethylation
- Cellular component
- nucleus;nucleoplasm;histone methyltransferase complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;transcription regulatory region DNA binding;metal ion binding